ELAB — PMGC Holdings Share News
0.000.00%
Last trade - 00:00- $2.15m
- -$7.24m
- $0.59m
U.S. STOCKS ON THE MOVE-Replimune, Snowflake, Virpax Pharmaceuticals
U.S. STOCKS ON THE MOVE-Snowflake, GE Vernova, EQT Corp
Elevai Labs falls after announcing 1-for-200 stock split
Brief: Elevai Labs Announces Reverse Stock Split To Maintain Nasdaq Listing Compliance
Brief: Elevai Labs Inc To Implement 1-For-200 Reverse Stock Split
Brief: Elevai Labs Inc. Announces Withdrawal Of Offer To Exchange And Plans To Reassess
Brief: Elevai Labs says Nasdaq Grants Co Exception To Cure Bid Price Deficiency
Brief: Elevai Labs Inc. Announces Update And Extension Of Pending Offer To Exchange
Brief: Elevai Biosciences highlights Past Positive Preclinical Data Showing Potential Of El-32, A Dual Myostatin & Activin-A Blocker, For The Treatment Of Obesity
Brief: L1 Capital Global Opportunities Master Fund Reports 9.99% Passive Stake In Elevai Labs
Brief: Elevai Labs Inc. Announces Pricing Of $8.0 Million Public Offering
Brief: ELEVAI Labs Subsidiary, Elevai Skincare Announces Positive Results For E-Series Exosome Technology In Potential Melasma Applications
Brief: Elevai Labs Inc - Jordan Plews, Notified Of His Intention To Resign As Chief Executive Officer Effective On The Close Of Business On June 21
Brief: Elevai Labs Forms New Scientific Advisory Board For Its Weight Loss Programs
U.S. STOCKS ON THE MOVE-Nvidia Corp, Royal Caribbean, Moderna
Brief: Inmune Bio Under Deal Elevai Will Make An Initial Deposit For License In Two Installments Over Six Months